Photo Gallery: India Battles Drug 'Evergreening'
11/28/2012
India has refused to recognize the patents of many multinational pharmaceutical...
Corbis

India has refused to recognize the patents of many multinational pharmaceutical companies. For six years, its Supreme Court has been hearing a case involving the Swiss pharmaceutical giant Novartis and the India state, which doesn't recognize the company's patent for the cancer drug Glivec. The Indian Patent Office argues that the drug is not a true novelty, but rather a variation of an existing drug meant to help extend its monopoly on the drug in a practice known as "evergreening."